These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3624497)

  • 21. [The "gray zone" in organized mammography screening: histocytological correlations].
    Bak M; Konyár E; Schneider F; Bidlek M; Szabó E; Nyári T; Godény M; Kásler M
    Orv Hetil; 2011 Feb; 152(8):292-5. PubMed ID: 21310698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of aspiration cytology within the scope of triple diagnosis of palpable breast changes].
    Schuhmann R; Hübner F; Brose C; Eckel S; Geier G; Kraus H; Schöndorf H; Schöndorf NK
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):553-8. PubMed ID: 8543127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of fine needle aspiration cytology from breast masses in Thailand.
    Nguansangiam S; Jesdapatarakul S; Tangjitgamol S
    Asian Pac J Cancer Prev; 2009; 10(4):623-6. PubMed ID: 19827882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fine-needle aspiration cytology or core biopsy when diagnosing tumours of the breast].
    Berner A; Sigstad E; Reed W; Risberg B
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1677-9. PubMed ID: 12821988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of cytopathologist-performed ultrasound-guided fine-needle aspiration as a screening test for ultrasound-guided core-needle biopsy in nonpalpable breast masses.
    Lieu D
    Diagn Cytopathol; 2009 Apr; 37(4):262-9. PubMed ID: 19217029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonpalpable breast lesions: evaluation by means of fine-needle aspiration cytology.
    Hann L; Ducatman BS; Wang HH; Fein V; McIntire JM
    Radiology; 1989 May; 171(2):373-6. PubMed ID: 2539608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-needle aspiration in the management of breast masses.
    Layfield LJ; Glasgow BJ; Cramer H
    Pathol Annu; 1989; 24 Pt 2():23-62. PubMed ID: 2671883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine needle aspiration cytology of breast lesions: a clinicocytologic review of 1211 cases.
    Taye AA; Gemechu T
    Ethiop Med J; 1998 Oct; 36(4):219-25. PubMed ID: 11957297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates.
    Snead DR; Vryenhoef P; Pinder SE; Evans A; Wilson AR; Blamey RW; Elston CW; Ellis IO
    Cytopathology; 1997 Aug; 8(4):236-47. PubMed ID: 9252741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
    Garg S; Mohan H; Bal A; Attri AK; Kochhar S
    Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to fine-needle aspiration cytology-negative cases of breast cancer.
    Mizuno S; Isaji S; Ogawa T; Tabata M; Yamagiwa K; Yokoi H; Uemoto S
    Asian J Surg; 2005 Jan; 28(1):13-7. PubMed ID: 15691791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. A comparative study of 124 women.
    Ballo MS; Sneige N
    Cancer; 1996 Aug; 78(4):773-7. PubMed ID: 8756371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine needle aspiration (FNA) cytology of the breast: the influence of unsatisfactory samples on patient management.
    Lazda EJ; Kocjan G; Sams VR; Wotherspoon AC; Taylor I
    Cytopathology; 1996 Aug; 7(4):262-7. PubMed ID: 8853973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.
    Ellis IO; Humphreys S; Michell M; Pinder SE; Wells CA; Zakhour HD; ;
    J Clin Pathol; 2004 Sep; 57(9):897-902. PubMed ID: 15333647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple test approach to inadequate fine needle aspiration biopsies of palpable breast lesions.
    Salami N; Hirschowitz SL; Nieberg RK; Apple SK
    Acta Cytol; 1999; 43(3):339-43. PubMed ID: 10349359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammography-guided stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: prospective comparison with surgical biopsy results.
    Fajardo LL; Davis JR; Wiens JL; Trego DC
    AJR Am J Roentgenol; 1990 Nov; 155(5):977-81. PubMed ID: 2120967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fine needle aspiration cytology of mammography screening].
    Engvad B; Laenkholm AV; Schwartz W; Bak M
    Ugeskr Laeger; 2009 Aug; 171(34):2379-82. PubMed ID: 19732519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast.
    Obdeijn IM; Brouwers-Kuyper EM; Tilanus-Linthorst MM; Wiggers T; Oudkerk M
    AJR Am J Roentgenol; 2000 Apr; 174(4):1079-84. PubMed ID: 10749254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of benign screen-detected breast lesions with suspicious preoperative needle biopsies.
    Shrestha DB; Ravichandran D; Baber Y; Allen S
    Eur J Surg Oncol; 2009 Feb; 35(2):156-8. PubMed ID: 18353607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.